| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/09/2009 | CA2699104A1 Use of a peptide as a therapeutic agent |
| 04/09/2009 | CA2699078A1 Use of grf-1 (1-29 ) and corticotropin-releasing factor as therapeutic agents |
| 04/09/2009 | CA2699074A1 Use of a peptide as a therapeutic agent |
| 04/09/2009 | CA2699067A1 Use of rfrp, alone or in combination with neurokinin-b, as a therapeutic agent |
| 04/09/2009 | CA2698690A1 Thyrotropin releasing hormone for therapeutic applications |
| 04/09/2009 | CA2698688A1 Use of a peptide as a therapeutic agent |
| 04/09/2009 | CA2698687A1 Use of a peptide as a therapeutic agent |
| 04/08/2009 | EP2045245A1 Inreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof |
| 04/08/2009 | EP2044936A1 Vitamin E Supplementation for enhancing immune response to Tetanus Toxoid |
| 04/08/2009 | EP2044930A1 Composition for controlling lipase catalyzed reactions |
| 04/08/2009 | EP2044850A1 Method for altering the metabolism characteristic of food products |
| 04/08/2009 | EP2044075A1 Furo [3, 2-b] pyrrol derivatives |
| 04/08/2009 | EP2044073A1 11beta-hydroxysteroid dehydrogenase type 1 active compounds |
| 04/08/2009 | EP2044057A2 Derivatives of ureas of piperidine or pyrrolidine, their preparation and their therapeutical use |
| 04/08/2009 | EP2044054A2 Pyrimidine and quinazoline derivatives as modulators of somatostatine receptor activity |
| 04/08/2009 | EP2044042A2 Polymorphic forms of { 2-methyl-4- [4-methyl-2- (trifluoromethylphenyl) thiazol-5-methylthiol phenoxy}-acetic acid |
| 04/08/2009 | EP2044040A2 1,3-oxazole derivatives useful as anti-atherosclerotic, anti-dyslipidemic, anti-diabetic and anti-obesity agents |
| 04/08/2009 | EP2044034A1 Alkyl-pyridazine derivatives as inhibitors of 11 beta hydroxysteroid dehydrogenase type 1(11b-hsd 1) |
| 04/08/2009 | EP2043744A2 Chemical compounds |
| 04/08/2009 | EP2043660A2 Composition having effect of treating, preventing, or improving diabetes or diabetic complication and drink comprising the same |
| 04/08/2009 | EP1814846B1 11beta-hsd1 inhibitors |
| 04/08/2009 | EP1706114A4 Chemical inhibitors of soluble adenylyl cyclase (sac) |
| 04/08/2009 | EP1682122B9 Combinations of valsartan, amiloride or triamterine, and a diuretic |
| 04/08/2009 | EP1513811B1 Non-peptidic brs-3 agonists |
| 04/08/2009 | EP1462518B1 Adipocyte differentiation-associated gene and protein |
| 04/08/2009 | EP1448566B3 Chemokine receptor antagonists and methods of use thereof |
| 04/08/2009 | EP1415986B1 Spiro isobenzofuranes as neuropeptide y receptor antagonists |
| 04/08/2009 | EP1212299B1 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 04/08/2009 | CN101405288A Imidazopyridin-2-one derivatives as inhibitors of endothelial lipase |
| 04/08/2009 | CN101405272A Novel solid forms of (4R)-1-[4-(2-chloro-5-fluorobenzoyl)amino-3-methoxybenzoyl]-1,2,3,5-tetrahydro-spiro[4H-1-benzazepine-4,1'-[2]cyclopentene]-3'-carboxylic acid |
| 04/08/2009 | CN101405020A Endothelin and endothelin receptor agonists in the treatment of metabolic diseases |
| 04/08/2009 | CN101405016A Lypolysis promoter |
| 04/08/2009 | CN101404996A Composition containing lignan compound |
| 04/08/2009 | CN101404995A Lignane compound-containing oil-in-water emulsion and composition comprising the same |
| 04/08/2009 | CN101404993A Ticonvulsant derivant used for preventing development of II type diabetes and X syndrome |
| 04/08/2009 | CN101402955A Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 04/08/2009 | CN101402923A Plant lactobacillus M1-UVs29 and uses thereof |
| 04/08/2009 | CN101402905A Fresh fruit white spirit and method of producing the same |
| 04/08/2009 | CN101402736A Biodegradable unsaturated polyphosphate, preparation and use method thereof |
| 04/08/2009 | CN101402692A Low-molecular weight crust polysaccharide unsaturated fatty acid salt, preparation and uses thereof |
| 04/08/2009 | CN101402681A Polypeptide from deer floral disc, preparing method and uses for preventing and treating diabetes |
| 04/08/2009 | CN101402633A Benzamide derivatives, preparation method and medical uses thereof |
| 04/08/2009 | CN101402600A Process for producing vitamin B6 |
| 04/08/2009 | CN101402583A Levorotation carnitine acid calcium phosphate, preparation method and use thereof |
| 04/08/2009 | CN101401939A Anti-activated state T cell antibody vaccine for preventing and/or treating immune correlated disease |
| 04/08/2009 | CN101401934A T cell component vaccine for preventing and/or treating immune correlated diseases |
| 04/08/2009 | CN101401908A Traditional Chinese medicine for reducing blood sugar, governing blood fat and anti-DNA damnification, and preparation method thereof |
| 04/08/2009 | CN101401849A Uses of tea polyphenol traditional Chinese medicine compound in preparing medicament for reducing blood fat and blood sugar |
| 04/08/2009 | CN101401839A Medicament composition for preventing birth-defect and improving memory |
| 04/08/2009 | CN101401838A Medicament composition for preventing birth-defect and improving memory |
| 04/08/2009 | CN101401837A Medicament composition for preventing birth-defect and improving memory |
| 04/08/2009 | CN101401836A Medicament composition for preventing birth-defect and improving memory |
| 04/08/2009 | CN101401835A Medicament composition for preventing birth-defect and improving memory |
| 04/08/2009 | CN101401821A Bee pollen peptide slice and preparation method thereof |
| 04/08/2009 | CN101401789A Cordyceps sinensis polysaccharide liposome medicament and preparation thereof |
| 04/08/2009 | CN101401785A Amino acid injection and preparation method thereof |
| 04/08/2009 | CN101401645A Medicament composition for preventing birth-defect and improving memory |
| 04/08/2009 | CN101401644A Medicament composition for preventing birth-defect and improving memory |
| 04/08/2009 | CN101401602A Bag tea for treating diabetes and preparing process |
| 04/08/2009 | CN100475953C Pancreatic stem cells |
| 04/08/2009 | CN100475939C A process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement and an animal feed product |
| 04/08/2009 | CN100475845C Phosphoinositolglycan (PIG)-binding protein from adipocytes |
| 04/08/2009 | CN100475843C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 04/08/2009 | CN100475829C Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents |
| 04/08/2009 | CN100475810C Novel 2-arylthiazole compounds as pparalpha and ppargamma agonists |
| 04/08/2009 | CN100475793C Quinazoline derivatives and use for preparing medicine |
| 04/08/2009 | CN100475790C Pyridyloxyalkanoic acid amide derivatives useful as fungicides |
| 04/08/2009 | CN100475757C Substance for use in dietary supplementation or for prepn. of medicament for treating non-insulin dependent diabetes mellitus, Hypertension and/or metabolic syndrome |
| 04/08/2009 | CN100475271C Somatostatin analogs with inhibitory activity to growth hormone release |
| 04/08/2009 | CN100475252C Chinese medicine for treating diabetes and preparation method thereof |
| 04/08/2009 | CN100475245C Medicine used for reducing weight, regulating fat metabolism and reducing blood fat |
| 04/08/2009 | CN100475244C Soft capsule for protecting liver, and lowering fat, and method for producing soft capsule of grape for protecting liver, and lowering fat from grape pericarp and grape seeds |
| 04/08/2009 | CN100475243C Hypoglycemic, antilipenic and hemopathy-treating glutinous rehmannia extract and preparing method thereof |
| 04/08/2009 | CN100475239C Quality control method of heart pulse free flow oral preparation |
| 04/08/2009 | CN100475232C Oral medicine for treating diabetes and use thereof |
| 04/08/2009 | CN100475231C Black soybean polysaccharides |
| 04/08/2009 | CN100475225C Soft capsule of ginseng fruit and preparing method thereof |
| 04/08/2009 | CN100475222C Beewax essence millimicrosphere preparation and uses in medicine |
| 04/08/2009 | CN100475213C Composition of an external dermatological agent and fibers with effect of promoting lipid decomposition |
| 04/08/2009 | CN100475208C Hyperlipemia therapeutic agent |
| 04/08/2009 | CN100475206C Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 04/07/2009 | US7514583 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 04/07/2009 | US7514571 Bicyclo derivative |
| 04/07/2009 | US7514564 Substituted amine derivatives and methods of use |
| 04/07/2009 | US7514555 Compounds for the treatment of metabolic disorders |
| 04/07/2009 | US7514471 2S)-3-(4-{2-[(Cyclohexylmethyl)(heptyl)amino]-2-oxoethoxy}phenyl)-2-ethoxypropanoic acid; treating lipid disorders (dyslipidemias), insulin resistance |
| 04/07/2009 | US7514469 Cyclooxygenase inhibitors; osteoarthritis, rheumatoid arthritis, and other injuries that result from overuse |
| 04/07/2009 | US7514456 Nicotinamide derivatives useful as p38 inhibitors |
| 04/07/2009 | US7514452 3-(4-hexylphenyl)-2-furancarboxylic acid 2-(4-hydroxy-3-nitrobenzoyl)hydrazide; nonpeptidergic glucagon receptor antagonist; orally; decrease blood sugar levels; hypoglycemic agent; dabetes mellitus type I and II, obesity, hyperlipidemia, gastrointestinal disorders |
| 04/07/2009 | US7514449 inhibitor of activated blood coagulation factor X; N-(5-chloropyridin-2-yl)-3- {[(trans-4-pyrrolidin-1 -ylcyclohexyl)carbonyl]aznino}furo[3,2-c]pyridine-2-carboxaxnide; disorders caused by thrombi and emboli in a mammal; decreased toxicity, and causes few side effects |
| 04/07/2009 | US7514445 Heteroaryl amines as glycogen synthase kinase 3β inhibitors (GSK3 inhibitors) |
| 04/07/2009 | US7514436 Antidiabetic agents; disease of glucose tolerance; insulin resistance; obesity; dyslipidemia; metabolic disorders; liver disorders; [4-(6-Phenethyloxy-pyridazin-3-yl)piperazin-1-yl]-(2-trifluoromethyl-phenyl)-methanone; stearoyl-CoA desaturase modulators |
| 04/07/2009 | US7514429 Benzoxazinone-derived compounds, their preparation and use as medicaments |
| 04/07/2009 | US7514422 To treat obesity, schizophrenia, anxiety, depression, alcoholism; using 3-benoazepine compounds like 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine (lorcaserin); serotonin 2c receptor agonists |
| 04/07/2009 | US7514244 Nutrients and nutraceuticals obtained from cultures of microorganisms, then recovering and using as feeds for infants |
| 04/07/2009 | US7514239 Nucleotide sequences coding polypeptide for use in the treatment of preferential glandular disorders |
| 04/07/2009 | US7514225 detecting drugs that inhibits the binding of macrophage migration inhibitory factor (MIF) to an antimacrophage migration inhibitor factor monoclonal or polyclonal antibody; drug screening |
| 04/07/2009 | US7514107 Treatment of diseases involving defective gap junctional communication |
| 04/07/2009 | US7514084 isolated nonapeptide that bind to an human leukocyte antigen (HLA-A 0201) restricted T cell receptors with high affinity and induce a high cytotoxic T lymphocyte response, used for treating or preventing tumors and cancers |
| 04/07/2009 | CA2490152C Oxazole derivatives and their use as insulin sensitizers |